Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
18.82
0.59 (3.24%)
At close: Aug 15, 2025, 3:59 PM
19.25
2.28%
After-hours: Aug 15, 2025, 05:00 PM EDT
Travere Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -169M | -225.9M | -320.73M | -349.06M | -410.08M | -426.06M | -376.33M | -353.56M | -307.44M | -288.84M | -278.48M | -264.23M | -230.22M | -202.19M | -180.09M | -250.14M | -237.05M | -224.11M |
Depreciation & Amortization | 50.15M | 46.48M | 43.55M | 43.32M | 37.67M | 41.23M | 40.89M | 38.34M | 41.33M | 35.53M | 33.08M | 29.83M | 29.12M | 27.64M | 26.62M | 27.2M | 25.77M | 25M |
Stock-Based Compensation | 39.38M | 38.65M | 36.91M | 35.84M | 38.55M | 40.53M | 44.25M | 45.63M | 43.72M | 44.46M | 39.18M | 38.23M | 36.38M | 31.04M | 30.77M | 28.54M | 26.95M | 25.61M |
Other Working Capital | -5.98M | -72.76M | -62.43M | -50.97M | -53.09M | 14.97M | 446K | -19.89M | -11.84M | -16.91M | -9.78M | 8.78M | 45.55M | 51.08M | 63.28M | 41.77M | 15.4M | 11.07M |
Other Non-Cash Items | -36.63M | 64.75M | 90.37M | 194.98M | 189.55M | 96.2M | 99.81M | -6.82M | 1.91M | 6.2M | 18.91M | 18.56M | 31.31M | 30.2M | 23.82M | 126.2M | 116.9M | 118.71M |
Deferred Income Tax | n/a | n/a | n/a | -109.42M | -59.84M | -63.17M | -63.17M | 46.26M | -3.33M | n/a | n/a | 1.44M | 2.5M | 2.67M | 4.12M | 2.71M | 2.84M | 2.89M |
Change in Working Capital | 663K | -60.07M | -63.02M | -63.32M | -60.14M | -6.35M | -25.48M | -34.03M | -20.77M | -9.85M | 904K | 17.54M | 43.84M | 67.01M | 79.98M | 63.7M | 37.48M | 11.84M |
Operating Cash Flow | -115.44M | -160.66M | -237.47M | -272.23M | -288.86M | -317.91M | -280.02M | -264.19M | -244.58M | -212.09M | -186.29M | -158.53M | -86.94M | -43.64M | -14.79M | -1.78M | -27.11M | -40.06M |
Capital Expenditures | -3.2M | -14.96M | -9.64M | -5.61M | -29.55M | -20.76M | -42.26M | -40.93M | -43M | -51.26M | -28.56M | -29.56M | -27.3M | -20.15M | -24.15M | -122.83M | -124.37M | -124.5M |
Cash Acquisitions | n/a | n/a | n/a | 12.65M | 18.21M | 21.41M | 48.75M | 36.1M | 20.46M | 17.26M | -4.94M | 9.06M | 24.16M | 28.37M | 28.01M | 27.04M | 26.52M | 26.45M |
Purchase of Investments | -190.13M | -125.76M | -125.76M | -62.65M | -218.28M | -340.75M | -443.94M | -465.58M | -404.52M | -462.3M | -385.39M | -346.04M | -347.61M | -324.52M | -547.08M | -574.1M | -584.22M | -458.81M |
Sales Maturities Of Investments | 243.92M | 268.13M | 326.33M | 321.29M | 354.67M | 351.82M | 334.57M | 336.96M | 361.54M | 411.4M | 381.99M | 387.12M | 408.87M | 345.92M | 433.6M | 426.43M | 362.4M | 376.73M |
Other Investing Acitivies | -50.42M | -103.48M | -98.08M | -109.45M | 118.36M | 179.53M | 158.66M | 169.47M | -21.69M | -56.95M | -34.75M | -48.16M | -63.26M | -28.37M | -28.01M | -27.04M | -26.52M | -26.45M |
Investing Cash Flow | 11.96M | 35.72M | 99.33M | 162.68M | 249.88M | 197.71M | 55.78M | 36.02M | -87.21M | -102.76M | -32.55M | 11.52M | 33.96M | 1.25M | -137.62M | -270.5M | -346.19M | -206.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 95.44M | 95.44M | 95.44M | 95.44M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.14M | 3.45M | -793K | -144K | -253K | 1.23M | 27.55M | 27.98M | 30.89M | 29.46M | 2.59M | 4.47M | 4.61M | 4.18M | 6.75M | 6.53M | 3.71M | 3.46M |
Financial Cash Flow | 144.36M | 143.66M | 139.42M | 427K | -253K | 1.23M | 218.75M | 219.18M | 222.09M | 220.66M | 117.57M | 150.24M | 150.37M | 149.84M | 231.68M | 223.51M | 220.75M | 329.24M |
Net Cash Flow | 42.86M | 18.65M | 359K | -107.83M | -38.58M | -118.13M | -3.51M | -7.09M | -108.89M | -95.2M | -104.06M | 1.01M | 96.47M | 108.34M | 80.98M | -50.15M | -153.88M | 81.21M |
Free Cash Flow | -118.28M | -175.26M | -246.76M | -277.48M | -318.4M | -338.67M | -322.28M | -305.11M | -287.58M | -263.35M | -214.85M | -188.09M | -114.24M | -63.79M | -38.94M | -124.62M | -151.49M | -164.56M |